Pyrrolo[2,3-
]carbazole derivatives as topoisomerase I inhibitors that affect viability of glioma and endothelial cells in vitro and angiogenesis in vivo
- 28/06/11
Corresponding author. Tel./Fax: +30 26 10 96 93 36.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 9 |
| Iconographies | 5 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Topoisomerase I is one of the most significant molecular targets through which indolocarbazoles inhibit tumour growth. In the present work, we studied the effect of new pyrrolo[2,3-⍺]carbazole derivatives on topoisomerase I activity in vitro, as well as on the viability of glioma and endothelial cells in vitro and on angiogenesis in vivo. All the tested compounds significantly decreased topoisomerase I activity in a concentration dependent manner, with the most effective being 1c, 1d1, 1d2 and 1f. The number of viable glioma and endothelial cells in vitro was also decreased in a concentration-dependent manner by all the tested compounds, although efficacy and potency differed in endothelial compared with glioma cells. Compounds 1c, 1d1, 1e and 1f were the most effective in glioma cells, while compounds 1d2 and 1e were the most effective in decreasing the number of viable endothelial cells. Finally, all the tested compounds inhibited angiogenesis in the chicken embryo chorioallantoic membrane in a significant and dose-dependent manner, with the most effective inhibitor being compound 1d2. These data suggest that the tested pyrrolo[2,3-⍺]carbazole derivatives inhibit topoisomerase I activity and may be potentially useful for inhibition of glioma cell growth and angiogenesis.
Le texte complet de cet article est disponible en PDF.Keywords : Angiogenesis, Cancer, Endothelial cells, Glioma, Indolocarbazoles, Pyrrolo[2,3-⍺]carbazoles, Topoisomerase I
Plan
Vol 65 - N° 3
P. 142-150 - juin 2011 Retour au numéro
Article précédent
- Lobaplatin suppresses proliferation and induces apoptosis in the human colorectal carcinoma cell Line LOVO in vitro
- Hong-yu Dai, Lin Liu, Shu-kui Qin, Xiang-ming He, Su-yi Li
- P21 (waf1/cip1) is required for non-small cell lung cancer sensitive to Gefitinib treatment
- Yi-Fan Zhao, Chong-Ren Wang, Yan-Ming Wu, Sheng-Lin Ma, Yuan Ji, Yan-Jun Lu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?